INHX Insider Trading Activity and SEC Form 4 Filings
INHX insider trading summary
No open-market insider purchases or sales of Inhibitex, Inc. (INHX) have been reported on SEC Form 4 in the past 12 months.
Latest INHX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 13, 2011 | Christopher McGuigan | Director | Sell | $722K (50,000 @ $14.43) |
| Dec 12, 2011 | Russell M Medford | Director | Sell | $18K (1,250 @ $14.50) |
| Nov 14, 2011 | Russell M Medford | Director | Sell | $12K (1,250 @ $9.25) |
| Nov 4, 2011 | Joseph M Patti | Chief Scientific Officer | Sell | $1.4M (174,596 @ $7.79) |
| Nov 4, 2011 | Christopher McGuigan | Director | Sell | $451K (50,000 @ $9.01) |
| Nov 4, 2011 | Joseph M Patti | Chief Scientific Officer | Sell | $280K (35,000 @ $8.00) |
| Nov 1, 2011 | Russell M Medford | Director | Sell | $1K (350 @ $4.00) |
| Oct 31, 2011 | Russell M Medford | Director | Sell | $4K (900 @ $4.00) |
| Sep 27, 2011 | QVT Fund LP | 10% Owner | Sell | $600K (200,000 @ $3.00) |
| Sep 27, 2011 | QVT Associates GP LLC | 10% Owner | Sell | $600K (200,000 @ $3.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.